Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH

The medical center is at the forefront of research in hematologic malignancies, focusing on innovative therapies for conditions such as acute myeloid leukemia (AML) and myelodysplastic syndrome. The center's trials explore the efficacy of novel drug combinations and personalized treatment approaches to improve patient outcomes.

• Acute Myeloid Leukemia (AML)
• Myelodysplastic Syndrome
• Acute Lymphoblastic Leukemia (ALL)

By integrating cutting-edge research with clinical practice, the center aims to enhance survival rates and quality of life for patients with these challenging conditions.

Specializing in neuro-oncology, the center conducts pivotal studies on glioblastoma and medulloblastoma. Research efforts are directed towards developing personalized therapies and improving the efficacy of existing treatment protocols.

• Glioblastoma
• Medulloblastoma
• Grade 2 or 3 Glioma

The center's commitment to advancing neuro-oncological care is evident in its exploration of novel therapeutic agents and vaccination strategies.

In the realm of critical care medicine, the center is pioneering research on sedation practices and adjunctive therapies for critically ill patients. Studies focus on optimizing sedation protocols and evaluating new treatment options for conditions like sepsis and septic shock.

• Sepsis and Septic Shock
• Critical Care Sedation

These efforts aim to improve patient outcomes in intensive care settings by refining therapeutic strategies and enhancing patient safety.

The center is actively involved in research on gastrointestinal oncology, with a focus on hepatocellular carcinoma and esophagogastric adenocarcinoma. Trials investigate the efficacy of novel drug combinations and treatment modalities to improve survival rates and quality of life.

• Hepatocellular Carcinoma
• Esophagogastric Adenocarcinoma
• Rectal Cancer

Through these studies, the center aims to advance therapeutic options and provide evidence-based care for patients with complex gastrointestinal cancers.

Focusing on lymphoma research, the center explores innovative treatment regimens for B-cell lymphoma and primary CNS lymphoma. The trials aim to assess the efficacy of novel therapeutic agents and optimize treatment protocols for better patient outcomes.

• Aggressive B-cell Lymphoma
• Primary CNS Lymphoma

By advancing research in this field, the center contributes to the development of more effective and targeted therapies for lymphoma patients.